|Oct, 2014||Founded Repertoire Genesis, Inc.|
|Nov, 2014||Raised 200 million yen in series A funding round through stock allocations to the University of Tokyo Edge Capital.|
|Set up a laboratory and office in Osaka, Japan|
|Dec, 2014||Immune diversity analysis service was started|
|Jun, 2015||We performed a contract service intermediation agreement with Wako Pure Chemical Industries Ltd. (presently FUJIFILM Wako Pure Chemical Corporation) and designated it as our exclusive agent in Japan.|
|May, 2016||Set up a branch office in Tokyo.|
|Jul, 2016||Raised 500 million yen in series B funding round through stock allocations to the University of Tokyo Edge Capital and Beyond Next Ventures.|
|Mar, 2017||A patent on new biomarkers for cancer immunotherapy was co-filed with Hyogo College of Medicine|
|Apr, 2017||Expansion of Osaka Laboratory (Head Office)|
|Jun, 2017||A basic patent on immune diversity analysis was established in Japan (Japanese Patent No. 6164759)|
|Aug, 2017||Raised 300 million yen in series C funding round through stock allocations to the University of Tokyo Edge Capital and Beyond Next Ventures.|
|Oct, 2017||We co-filed with Hiroshima University, two patents relating to the complete replacement of T cell receptors contributing to novel cell therapy|
|Aug, 2018||We co-filed a new patent with the National Center of Neurology and Psychiatry, on Biomarker of Myoblastic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) by B Cell Receptor (BCR) Repertoire|
|Aug, 2018||We applied for a patent of amplification technology of TCR/BCR pair gene from a single cell|
|Oct, 2018||Expansion & Relocation Osaka Laboratory (Head Office)|
About the our logo
The blue triangle means that a commercial-level repertoire analysis technology was developed for the first time by fusing three technologies: unbiased gene amplification, next generation sequencing, and repertoire analysis algorithm.
Further, the triangle is divided into four contrasts symbolizing the four professionals/founders that cooperated with each other [i.e. Ryuji Suzuki (Experimental Technology Development), Tadasu Shin-i (Software Development), Takaji Matsutani (Technology Improvement), and Kazutaka Kitaura (Transition to NGS)]. Since Repertoire Analysis is based on genetic analysis, we placed an abstract image of the DNA helical structure in the center.
The company's name was the one originally attached to the repertoire analysis algorithm. However, we decided to use it since it became a breakthrough in the development of the key software for the establishment of the company.
"We decided ""Trajan pro"" as a company name, which is located at the bottom of the logo.
It is because we felt sympathy for both the beauty and the degree of completeness and the formality which can be used also for the title of the movie."